Access

News

Nature 435, 548 (2 June 2005) | doi:10.1038/435548b; Published online 1 June 2005

Open Innovation Challenges

naturejobs

Drug giants fail to name compounds in trial database

Meredith Wadman

Top

Critics charge that negative results are deliberately obscured.

An international group of medical editors is challenging several leading pharmaceutical companies, saying that their reporting of clinical trials is deliberately incomplete.The International Committee of Medical Journal Editors made their complaint in an editorial in The New England Journal of Medicine, published online on 23 May.